The safety evaluation of the new drug is conducted through clinical trials involving a wide range of animal species. This includes observing any side effects from short-term and long-term administration of the drug.
Particular attention is paid to chronic health impacts and the drug’s effects on specific health conditions. The impact of the drug on the physiological and behavioral characteristics of pets is also thoroughly evaluated.
The results of the safety evaluation are submitted to regulatory authorities before the drug’s market launch and are a critical criterion for approval. Safety evaluation is essential to ensure the health and safety of both pets and owners.